Supplement: Taking the Bite out of COPD

Taking the Bite out of COPD By Jack Lucentini ARTICLE EXTRAS Innovative Technology Technology Roundup Greater Philadelphia Innovation --> Bristol Myers-Squibb Rutgers-Camden Institute Neuronetics Absorption Systems University of Pennsylvania Tengion Kimmel Cancer Center Orphagenix BioNanomatrix In dry medical jargon, it's called an exacerbation. For the patients, it's a frightening, wrenching assault on the body that som

Written byJack Lucentini
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Innovative Technology

Technology Roundup

Bristol Myers-Squibb

Rutgers-Camden Institute

Neuronetics

Absorption Systems

University of Pennsylvania

Tengion

Kimmel Cancer Center

Orphagenix

BioNanomatrix

In dry medical jargon, it's called an exacerbation. For the patients, it's a frightening, wrenching assault on the body that some liken to drowning. It happens to people with chronic obstructive pulmonary disease, or COPD, and consists of a rapid or sudden worsening of the condition's symptoms: shortness of breath, cough, and mucus buildup. Gerard Criner, professor of medicine of Temple University School of Medicine, has an idea to ease the burden - not through any new treatments as such, but by means of handheld computers or cell phones.

An exacerbation is "the equivalent of a heart attack for people who have COPD," Criner says. Most patients, however, fail to call their doctors as signs and symptoms leading to the crisis worsen. "If you get a doctor sooner than ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies